Thermo Fisher Scientific (TMO) exceeds expectations in Q4 2025 earnings

According to CoinWorld, Thermo Fisher Scientific announced strong results for the fourth quarter of fiscal year 2025, with revenue reaching $12.21 billion, a 7% year-on-year increase, surpassing the previous expectation of $11.95 billion. Adjusted earnings per share rose 8% to $6.57, higher than the earlier forecast of $6.45. The company's growth was mainly driven by robust demand in its core business segments and the launch of strategic products. Looking ahead to 2026, Thermo Fisher Scientific plans to maintain its growth momentum through strategic acquisitions and technological collaborations, including partnerships with the Chan Zuckerberg Initiative and OpenAI.